<img alt="" src="https://secure.agile-company-365.com/781893.png" style="display:none;">
remote-home-blood-micro-sampling

new convenience in capillary blood sampling

Better Blood Collection for Vulnerable Patients
Vulnerable Populations Case Studies, a survey of needle free option to taking blood. Micro capillary blood collection is a simple and less traumatic alternative to venipuncture
“We can now sit at home and do a sample using the device, send it off, and get an accurate result without having to leave the comfort of our own home – It’s a lot less stressful, plus we don’t need to take a whole day out just to go for a blood test or clinic visit, which makes school attendance better.”

-Caroline Knapp, mother of a young kidney transplant patient

To better serve pediatric patients, the elderly, and other vulnerable populations, leaders in healthcare are looking for an alternative to venipuncture. They're discovering the revolutionary capabilities of breakthrough Volumetric Absorptive Microsampling (VAMS®) technology - a smarter blood collection system using Mitra® devices to streamline clinical processes, improve the patient experience, and generate gold-standard data.


Now it's your turn! Download these case studies to see how large and small organizations use microsampling technology as a more convenient and comfortable next-generation dried blood spot.

  • Produce bioanalytical results that bridge to plasma references - even when taking blood from a baby
  • Store and ship Mitra® blood specimens with no biohazard or cold-chain shipping.
  • Enable simple, cost-effective remote sampling for remote patient monitoring, precision medicine, and virtual clinical trials 
  • Collect precise and accurate blood samples without trained clinical staff 
alternative to venipunture case studies for vulnerable Populations
"VAMS technology allows convenient at-home monitoring and is minimally invasive. It also offers efficiencies in the clinical setting, as providers will have blood results in hand before meeting with the patient."

~Dr. Christophe Stove | Ghent University Hospital

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Trajan_logo_footer_wht

Contact Us
Trajan Scientific Americas Inc.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Get To Know Us

Follow Us

Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine. 

In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements. 

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. 

Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group. 

Copyright © 2022. All rights reserved.